Digging Up the Facts on Allergan plc (AGN)

Allergan plc (AGN) is an interesting player in the Healthcare space, with a focus on Drugs – Generic. The stock has been active on the tape, currently trading at $234.76, up from yesterday’s close by 0.74%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Allergan plc (AGN) currently trades with a market capitalization of $78.43 Billion. That value represents a market adjusting for revenues that have been growing by 5.11 % on a quarterly year/year basis as of the company’s last quarterly report.



The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For AGN, the company currently has $1.09 Billion of cash on the books, which is offset by $5.53 Billion current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $645.9 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $4 on a per share basis this quarter. Perhaps, that suggests something about why 68.17% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Allergan plc recorded a 52-week high of $261.27. It is now trading 26.51% off that level. The stock is trading $232.99 its 50-day moving average by -1.77%. The stock carved out a 52-week low down at $184.50.

In recent action, Allergan plc (AGN) has made a move of +6.55% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.15, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.03% with $334.08 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AGN.

SHARE
Previous articleCMS Energy Corporation (CMS): From Top to Bottom
Next articleFedEx Corporation (FDX): What’s the Story?